Why the study?
To ascertain the proportion of clinical trials underpinning current international STEMI management guidelines that reported patients with no standard modifiable risk factors as a separate group.
Answers are grounded in this paper and cite their sources.
Highlights a potential gap in reporting patients without standard modifiable risk factors in STEMI clinical trials.
No abstract yet. The journal hasn't published one we can show.
No takes yet. Share an insight, caveat, or question.
Avis et al. (2021) studied this question.
Synapse has enriched 10 related papers. Consider them for comparative context: